论文部分内容阅读
Depomed公司的新剂型GraliseTM(缓释加巴喷丁片剂)在美国上市,每日给药1次,用于治疗带状疱疹后神经痛。本品已有规格包括30d起始包(可在15d内滴定至全剂量)以及瓶装600和300mg片剂。
Depomed’s new dosage form GraliseTM (sustained release gabapentin tablets) is marketed in the United States administered once daily for the treatment of postherpetic neuralgia. This product has specifications including the initial package 30d (titration to full dose within 15d) and bottled 600 and 300mg tablets.